glp-1 obesity injector components Drugs Significantly Affect POAG Risk in Obese Patients Targeting GLP-1, GIP & GCG
Description
In general, stimulant-based supplements should only be used occasionally and ideally with professional guidance
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications increasingly prescribed for type 2 diabetes management and weight loss
People with diabetes have had a hard time getting ahold of their medications because of the shortages, with some rationing their drugs to cope with the lack of supply, NPR reported
Wilding et al., 2021) or the GIP/GLP-1 dual receptor agonist tirzepatide (Rosenstock et al., 2021
Aim for 25-30 grams of protein at breakfast when taking GLP-1 medications
As a result, GLP-1RAs should not be prescribed for treating BED
